Differential protein expression analysis using stable isotope labeling and PQD linear ion trap MS technology

J Am Soc Mass Spectrom. 2009 Jul;20(7):1287-302. doi: 10.1016/j.jasms.2009.02.029. Epub 2009 Mar 4.

Abstract

An isotope tags for relative and absolute quantitation (iTRAQ)-based reversed-phase liquid chromatography (RPLC)-tandem mass spectrometry (MS/MS) method was developed for differential protein expression profiling in complex cellular extracts. The estrogen positive MCF-7 cell line, cultured in the presence of 17beta-estradiol (E2) and tamoxifen (Tam), was used as a model system. MS analysis was performed with a linear trap quadrupole (LTQ) instrument operated by using pulsed Q dissociation (PQD) detection. Optimization experiments were conducted to maximize the iTRAQ labeling efficiency and the number of quantified proteins. MS data filtering criteria were chosen to result in a false positive identification rate of <4%. The reproducibility of protein identifications was approximately 60%-67% between duplicate, and approximately 50% among triplicate LC-MS/MS runs, respectively. The run-to-run reproducibility, in terms of relative standard deviations (RSD) of global mean iTRAQ ratios, was better than 10%. The quantitation accuracy improved with the number of peptides used for protein identification. From a total of 530 identified proteins (P < 0.001) in the E2/Tam treated MCF-7 cells, a list of 255 proteins (quantified by at least two peptides) was generated for differential expression analysis. A method was developed for the selection, normalization, and statistical evaluation of such datasets. An approximate approximately 2-fold change in protein expression levels was necessary for a protein to be selected as a biomarker candidate. According to this data processing strategy, approximately 16 proteins involved in biological processes such as apoptosis, RNA processing/metabolism, DNA replication/transcription/repair, cell proliferation and metastasis, were found to be up- or down-regulated.

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Biomarkers, Tumor / analysis
  • Biomarkers, Tumor / biosynthesis
  • Breast Neoplasms / metabolism
  • Cell Line, Tumor
  • Chromatography, Liquid / methods
  • Electrophoresis, Gel, Two-Dimensional
  • Estradiol / pharmacology
  • Female
  • Humans
  • Isotope Labeling / methods*
  • Neoplasm Proteins / analysis
  • Neoplasm Proteins / biosynthesis
  • Protein Biosynthesis
  • Proteins / analysis*
  • Reproducibility of Results
  • Tamoxifen / pharmacology
  • Tandem Mass Spectrometry / methods*

Substances

  • Biomarkers, Tumor
  • Neoplasm Proteins
  • Proteins
  • Tamoxifen
  • Estradiol